Glaxo delays cancer drug filing for year (Reuters)


Reuters - GlaxoSmithKline Plc's
experimental cancer pill lapatinib is effective as a first-line
breast cancer treatment, but regulatory approval will not be
sought before late 2006 or early 2007 after more data is
collected, the company said on Sunday.

Read more...